Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Daily Intelligence Tracker
    • Plans Blog Contact
    Abiomed, Inc. logo
    ABMD

    Abiomed, Inc.

    MaveScore 15 Low model confidence
    Last Price N/A As of Updating
    DCF Fair Price US$93.55 Research estimate · Jul 10, 2026 -75.4% vs price
    Market Cap N/A Company size context
    7D Performance N/A Past 7 days
    1Y Performance N/A Past 12 months
    Model Rating
    Historical model output for research review

    Fundamental data date

    Sep 30, 2022

    1380 days old

    Market price date

    Updating

    Refreshing

    Coverage

    7/16

    9 missing model inputs

    Data quality

    Limited

    Limited stored snapshot

    Transparent research score

    Why the model scores this stock

    MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

    MaveScore 15 Low confidence

    Stored data quality

    Freshness and coverage checks

    7/16 Limited stored snapshot

    Quality

    0/35 Weak

    Blends latest model rank with profitability and dilution ranks.

    Financial Strength

    14/25 Mixed

    Rewards durable profitability, margins, and positive free cash flow.

    Valuation Support

    1/15 Weak

    Favors positive earnings, positive cash flow, and lower multiples.

    Momentum

    0/15 Needs Data

    Momentum needs recent 3-month or 6-month price-change data.

    Shareholder Alignment

    0/10 Needs Data

    Shareholder alignment needs share-count rank or market-cap data.

    Positive model output

    More live company inputs are needed before positive research signals can be surfaced.

    Research risks to review

    • Blends latest model rank with profitability and dilution ranks.
    • Favors positive earnings, positive cash flow, and lower multiples.
    • Momentum needs recent 3-month or 6-month price-change data.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include EPS rank, ROE rank, net margin rank, share-count rank, leverage rank, latest price, 3-month price change, 6-month price change, market cap.

    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Abiomed, Inc. Overview

    Industry: -

    Sector: -

    Read More

    Abiomed, Inc. is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

    Abiomed, Inc.

    Score

    Reported Results

    No latest earnings report cached yet

    Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.

    Recent News



    Earnings Per Share

    Score 0/5
    Abiomed, Inc. Financial ratio data is updating.
    In - industry , United States Natural Gas Fund, LP , Earth Science Tech, Inc. , Invesco DB Energy Fund are companies with high ratings.

    Return on Equity

    Score 0/5
    Abiomed, Inc. Financial ratio data is updating.
    Abiomed, Inc... ABMD N/A

    Net Margin

    Score 0/5
    Abiomed, Inc. Financial ratio data is updating.
    Abiomed, Inc... ABMD N/A

    Share Buyback

    In - industry , United States Natural Gas Fund, LP , Earth Science Tech, Inc. , Invesco DB Energy Fund are companies with high ratings.

    Leverage

    Score 0/5
    Abiomed, Inc. F i
    Abiomed, Inc... ABMD N/A

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    SEC financial statements are temporarily unavailable.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Abiomed, Inc. logo

    Abiomed, Inc.

    N/A

    US$93.55

    -75.4% vs price

    N/A

    N/A

    N/A